If you have been reading about pentadecapeptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-10-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
Standard practice for the solid form is storage at minus twenty degrees Celsius or colder, kept dry and away from light. Containers are usually sealed with a desiccant to limit moisture uptake. Reconstituted solutions are typically held at two to eight degrees Celsius and used within a short window, because potency can decline over days to weeks depending on the buffer and concentration. Freezing an already dissolved sample may help, though repeated thawing is discouraged. Specific shelf-life claims vary between suppliers and are rarely supported by published stability studies.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometers, a wavelength that captures the peptide backbone. The main peak area is reported as a percentage of total peak area, which serves as a conventional purity figure. Mass spectrometry provides an independent check on molecular mass and helps confirm the expected sequence. Additional tests may include amino acid analysis and water content determination. Results are only comparable when the same column, gradient, and detection settings are used.
| Property | Value | Notes |
|---|---|---|
| Molar mass | Approximately 1419.5 g/mol | Calculated from the reported 15-residue sequence |
| Molecular formula | C62H98N16O22 | Based on the same sequence |
| Appearance | White to off-white powder | Typical of a lyophilized preparation |
| Solubility class | Freely soluble in water | Also dissolves in saline solutions |
| Typical storage temperature | Minus 20 degrees Celsius, dry | Refrigeration advised after reconstitution |
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
=== Family record book (1877) === The loss of Parisian civil records largely influenced the creation of the family record book in 1877, introduced by a circular from Jules Simon, President of the Council and Minister of the Interior. The circular explicitly referenced the Commune’s destruction, stating that “family record books will serve as a third deposit of civil records entrusted to individuals and will provide valuable information should registers be destroyed.” The law of April 5, 1884, concerning municipal organization, required town halls to budget for the costs of family record books.
Though some studies indeed find this correlation, the consistent correlation between ophthalmic acid increases and glutathione depletion does not exist. Compared to a healthy baseline, both can go up, both can go down, or ophthalmic acid can go up with no changes in glutathione. A study on circadian rhythm tracking both glutathione and ophthalmic acid levels determined that ophthalmic acid levels were rhythmic, while glutathione levels were not. Ophthalmic acid trends also differ wildly between different tissues in the same animal at the same timepoint, again dispelling the notion of a broader and consistent correlation. The meaning of "biomarker" is much more narrow in this context than many studies assume. Importantly, the Soga et al. study sees a correlation between depleting hepatic glutathione levels, and rising ophthalmic acid levels in plasma, in mice. It solves the practical problem of not being able to directly measure an established glutathione depletion in liver by measuring ophthalmic acid in plasma. However, subsequent studies often measure both glutathione and ophthalmic acid, and when glutathione shows no aberration, ophthalmic acid is used as a "marker" to still claim oxidative stress. There cannot be an appeal to a correlation when the data itself disproves that very correlation. Ophthalmic acid can be found in high concentrations in healthy tissues. For instance in the eye. It is not solely found in stressed or diseased states.
== Structure of the peptide bond == In 1937, Huggins analyzed the β-sheet models of William Astbury and realized that the hydrogen bonding could not work as described since the bond geometry of the amide nitrogen (then presumed to be tetrahedral) would deflect the hydrogen away from the carbonyl oxygen. He further suggested that resonance might play a role in changing the geometry of the peptide bond to make the hydrogen bonds more linear. However, he did not state explicitly that the peptide bond was planar, as emphasized by Pauling in a nearly simultaneous paper.
== Reported incidents == In 2017 the BBC reported a case in which a male hedgehog was "almost twice its natural size, literally blown up like a beach ball with incredibly taut skin". The head vet at Stapeley's Wildlife Hospital, Bev Panto, said, "In my career I have seen three or four of these cases and they are very strange every time and quite shocking [...] When you first see them they appear to be very big hedgehogs but when you pick them up they feel so light because they are mostly air". She added that the condition was unique to hedgehogs because they have significant space under their skin as a result of their ability to curl up. A similar case had been reported in 2013. In 2024, a hedgehog that was spotted by a passing bus passenger "swollen to the size of a football" was successfully deflated by rescuers in Gloucestershire.
Sources: en.wikipedia.org
Due to his insecurity about his Persian heritage, he distanced himself from his culture and bullied others to avoid getting bullied himself, though he has regrets about this. He has naturally black hair that he dyes blond for most of the book, light brown skin, and black eyes. He is homosexual. Anna Lightwood — regarded as a bit of a bohemian, Anna is a quite popular with the ladies but disapproved of by the older generation for her lifestyle choices and for dressing like a man. She acts as an older sister to the others and often does her best to look out for and assist them. She is genderqueer, and dates women, though she does not like to commit after having her heart broken by Ariadne Bridgestock, her first love. Like Matthew, Anna is very stylish. She has black hair and blue eyes. Ariadne Bridgestock — the adopted daughter of the Inquisitor. She was engaged to Charles Fairchild, though he later breaks it off. Ariadne is secretly a lesbian and has a history with Anna. She is determined to win Anna back after initially losing her due to her engagement with Charles. Grace Blackthorn — the mysterious adopted daughter of Tatiana Blackthorn whom James is in love with. She seems meek and frail but is actually quite cold and calculating. Tatiana Blackthorn — a maddened woman who seeks revenge and to resurrect her dead son. The London Enclave — governing body of the local Shadowhunters, which consists of Will Herondale, Tessa Gray, Charles Fairchild, Henry Branwell, Gabriel Lightwood, Gideon Lightwood, Sophie Collins, and Cecily Herondale.
1-Docosanol Alcohols: Ethanol Isopropyl alcohol n-propanol Benzalkonium chlorides, e.g., Alkyl dimethyl benzyl ammonium chlorides (C12-16) Alkyl dimethyl benzyl ammonium chloride (C14 60%, C16 30%, C12 5%, C18 5%) Alkyl dimethyl ethylbenzyl ammonium chloride (C12-14) Alkyl dimethyl ethylbenzyl ammonium chlorides (C12-18) Bleach (Sodium hypochlorite) Sodium hypochlorite washes Didecyldimethylammonium chloride Hand washing (see also Surfactants) Hand washing is a mechanical process of removing germs and viruses, and chemicals. Hand washing with, e.g., ethanol added to a hand disinfectant shows virucidal effects, but caution is given (small children) and it is not recommended over "proper hand washing". Hand gels are often found to not comply with EN 1500 standards to meet antimicrobial efficacy. Prof. Graham Ayliffe's hand-cleaning and disinfection technique is promoted nowadays by the WHO and is similar to German standard DIN EN 1500 (hygienic hand disinfection). Hydrogen peroxide Oral rinse (see Cochrane systematic review in case of SARS-CoV-2) Chlorhexidine (CHX) - mainly against enveloped viruses. Dequalinium Povidone-iodine (Isodine, PVP-I), High potency for virucidal activity has been observed against viruses of significant global concern, including hepatitis A and influenza, as well as the Middle-East Respiratory Syndrome and Sudden Acute Respiratory Syndrome coronaviruses. Application types and names: Isodine, Scrub, Isodine Nodo Fresh Surfactants Soap Triton X-100
Johnny Rep, former Ajax player, claimed that "everyone was on something". He recounted injections for everyone on 1 November 1979, ahead of a match of his team, Saint-Etienne, against PSV Eindhoven. Pierre Poty, who was physician of the club at that time, also revealed that he worked with uppers and reasoned it with the fantastic effects. Fritz Kessel, also physician, worked for the Dutch national side for 30 years and revealed that drugs were common in the 1974 and 1978 FIFA World Cups. He said that to Guido Derksen, writer of Voetbal Mysteries, who wrote that players "consumed tons of amphetamines." An investigative commission of sports medicine in Freiburg claims that in the late 1970s and in the 1980s Stuttgart and Freiburg football clubs were operating with Anabolika. VfB Stuttgart reordered Anabolika at least once. In 1987, Toni Schumacher wrote about a long-running tradition of doping in the Bundesliga, claiming that lots of players were taking Captagon. He himself experimented with it and the effects were: Increased aggression, lower pain threshold, increased focus, confidence and endurance. The by effect was sleeping problems. In Köln he was chauffeuring his colleagues to the doctor who gave them pills and injections, presumably anabolics and stimulants. In the national team he mentioned a "walking chemist" and hormone use. Despite being supported by Paul Breitner he had to leave Köln after 544 games.
Sources: en.wikipedia.org
It does not occur in the form that is supplied commercially. Its sequence matches a fragment of a larger gastric protein, and the research material is produced synthetically in a laboratory. The fragment described in the early literature is generally the same synthetic pentadecapeptide.
It marks the position of the sequence inside the original protein. The label traces back to early work fractionating gastric juice and describing a body protection compound. The figure does not refer to molecular weight or to the count of amino acids.
No. The sequence has no cysteine residues, so disulfide bridges cannot form. That feature makes it easier to handle than many small proteins that depend on multiple cysteines for structure.
Reversed-phase HPLC separates the sample into peaks, and the main peak is expressed as a percentage of total peak area. Mass spectrometry is then used to confirm that the molecular mass matches the expected value.